The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC).
Ontology highlight
ABSTRACT: Purpose: Platinum derivatives, such as cisplatin (DDP), carboplatin and oxaliplatin, are widely used components of modern cancer chemotherapy including esophageal squamous cell cancer (ESCC). However, their roles are limited by the impact of intrinsic/acquired resistance mechanisms on tumor responses. Recent studies have shown that the mammalian copper transporters CTR1, ATP7A and ATP7B are involved in cisplatin-resistance to some cancers. Methods: The cytotoxicities of DDP in different cell lines were determined using the MTT assay. To determine whether knockdown the expression of ATP7A could reverse the platinum-resistance of EC109/DDP cells or not, we used RNA interference system to explore the role of ATP7A in platinum resistance. Results: We found that DDP-resista
SUBMITTER: Li ZH
PROVIDER: S-EPMC5118672 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
ACCESS DATA